Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-14 Purchase |
2022-07-14 6:25 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
7,187 | $1.8122 | $13,024 | 5,809,044 (Indirect) |
View |
| 2022-07-12 Purchase |
2022-07-14 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
6,000 | $1.855 | $11,130 | 258,018 (Direct) |
View |
| 2022-06-24 Purchase |
2022-06-27 4:05 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
11,419 | $1.3919 | $15,894 | 5,801,857 (Indirect) |
View |
| 2022-06-21 Purchase |
2022-06-23 6:54 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
841,989 | $1.3127 | $1,105,279 | 9,229,713 (Indirect) |
View |
| 2022-05-09 Purchase |
2022-05-11 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
10,000 | $1.85 | $18,500 | 252,018 (Direct) |
View |
| 2022-05-10 Purchase |
2022-05-10 7:58 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
9,700 | $1.7559 | $17,032 | 3,585,420 (Indirect) |
View |
| 2022-05-06 Purchase |
2022-05-10 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
2,500 | $1.97 | $4,925 | 242,018 (Direct) |
View |
| 2022-04-29 Purchase |
2022-05-03 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
5,000 | $1.9709 | $9,855 | 239,518 (Direct) |
View |
| 2022-04-22 Purchase |
2022-04-29 6:27 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
7,100 | $1.98 | $14,058 | 3,584,220 (Indirect) |
View |
| 2022-04-22 Purchase |
2022-04-25 5:55 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
52,777 | $2.2252 | $117,438 | 3,583,220 (Indirect) |
View |
| 2022-04-21 Purchase |
2022-04-25 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
4,500 | $2.3 | $10,350 | 234,518 (Direct) |
View |
| 2022-04-13 Purchase |
2022-04-14 6:13 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
20,041 | $2.4994 | $50,091 | 3,578,147 (Indirect) |
View |
| 2022-04-11 Purchase |
2022-04-12 7:38 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
27,198 | $2.4578 | $66,846 | 3,573,106 (Indirect) |
View |
| 2022-04-08 Purchase |
2022-04-12 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
2,000 | $2.5 | $5,000 | 226,518 (Direct) |
View |
| 2022-03-30 Purchase |
2022-04-01 06:05 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
4,000 | $2.7 | $10,800 | 224,518 (Direct) |
View |
| 2022-03-29 Purchase |
2022-03-30 07:20 am |
Tracon Pharmaceuticals Inc. | TCON | Brown Scott B. Chief Financial Officer |
1,000 | $2.82 | $2,820 | 8,628 (Direct) |
View |
| 2022-03-21 Purchase |
2022-03-23 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
1,200 | $2.45 | $2,940 | 220,518 (Direct) |
View |
| 2022-03-16 Purchase |
2022-03-17 4:05 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
2,235 | $2.2 | $4,917 | 6,085,841 (Indirect) |
View |
| 2022-01-28 Purchase |
2022-01-31 4:05 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
500 | $2.2 | $1,100 | 6,068,606 (Indirect) |
View |
| 2022-01-21 Purchase |
2022-01-24 6:18 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
52,363 | $2.1468 | $112,414 | 3,565,469 (Indirect) |
View |
| 2022-01-19 Purchase |
2022-01-21 4:00 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
45,000 | $2.2452 | $101,032 | 3,558,106 (Indirect) |
View |
| 2021-12-29 Purchase |
2021-12-29 7:14 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
52,325 | $2.5105 | $131,362 | 3,553,106 (Indirect) |
View |
| 2021-12-27 Purchase |
2021-12-29 4:05 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
107,450 | $2.8669 | $308,052 | 3,533,106 (Indirect) |
View |
| 2021-12-15 Purchase |
2021-12-16 4:01 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
21,964 | $2.4261 | $53,287 | 3,501,181 (Indirect) |
View |
| 2021-12-13 Purchase |
2021-12-15 4:05 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
57,204 | $2.561 | $146,498 | 3,499,217 (Indirect) |
View |
| 2021-12-03 Purchase |
2021-12-07 4:05 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
112,007 | $2.289 | $256,385 | 3,491,013 (Indirect) |
View |
| 2021-12-01 Purchase |
2021-12-03 5:14 pm |
Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner |
60,500 | $2.3937 | $144,820 | 3,479,006 (Indirect) |
View |
| 2021-11-18 Purchase |
2021-11-22 4:21 pm |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
4,181 | $2.8298 | $11,831 | 219,318 (Direct) |
View |
| 2021-11-05 Purchase |
2021-11-09 07:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
4,000 | $3.4137 | $13,655 | 215,137 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-14 Option Award |
2022-06-16 9:49 pm |
N/A 2032-06-13 |
Tracon Pharmaceuticals Inc. | TCON | Twiford J Rainer Director |
15,750 | $0 | 15,750 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 9:36 pm |
N/A 2032-06-13 |
Tracon Pharmaceuticals Inc. | TCON | WORLAND STEPHEN T Director |
15,750 | $0 | 15,750 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 9:34 pm |
N/A 2032-06-13 |
Tracon Pharmaceuticals Inc. | TCON | LARUE WILLIAM R Director |
15,750 | $0 | 15,750 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 9:23 pm |
N/A 2032-06-13 |
Tracon Pharmaceuticals Inc. | TCON | MATTINGLY MARTIN A Director |
15,750 | $0 | 15,750 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 9:18 pm |
N/A 2032-06-13 |
Tracon Pharmaceuticals Inc. | TCON | Lam Carol C. Director |
15,750 | $0 | 15,750 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 9:14 pm |
N/A 2032-06-13 |
Tracon Pharmaceuticals Inc. | TCON | PELLETIER SAUNDRA L Director |
15,750 | $0 | 15,750 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 9:11 pm |
N/A 2032-06-13 |
Tracon Pharmaceuticals Inc. | TCON | Johnson-Pratt Lisa Director |
15,750 | $0 | 15,750 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 5:00 pm |
N/A 2032-01-27 |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
265,000 | $0 | 265,000 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 5:00 pm |
N/A 2032-01-27 |
Tracon Pharmaceuticals Inc. | TCON | WIGGINS MARK C Chief Business Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 5:00 pm |
N/A 2032-01-27 |
Tracon Pharmaceuticals Inc. | TCON | Brown Scott B. Chief Financial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-10-12 Option Award |
2021-10-13 8:26 pm |
N/A 2031-10-11 |
Tracon Pharmaceuticals Inc. | TCON | Lam Carol C. Director |
21,000 | $0 | 21,000 (Direct) |
View |